CLBAX
Price
$41.01
Change
+$0.10 (+0.24%)
Updated
Jun 2 closing price
Net Assets
278.87B
QKBGX
Price
$23.64
Change
-$0.00 (-0.00%)
Updated
Jun 2 closing price
Net Assets
330.95M
Interact to see
Advertisement

CLBAX vs QKBGX

Header iconCLBAX vs QKBGX Comparison
Open Charts CLBAX vs QKBGXBanner chart's image
CLBAX vs QKBGX Comparison Chart in %
View a ticker or compare two or three
VS
CLBAX vs. QKBGX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLBAX is a Hold and QKBGX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CLBAX has more cash in the bank: 279B vs. QKBGX (331M). CLBAX pays higher dividends than QKBGX: CLBAX (1.78) vs QKBGX (1.35). CLBAX was incepted earlier than QKBGX: CLBAX (24 years) vs QKBGX (19 years). QKBGX (1.05) is less costly to investors than CLBAX (0.58). QKBGX is a more actively managed with annual turnover of: 82.00 vs. CLBAX (50.00). QKBGX has a lower initial minimum investment than CLBAX: QKBGX (0) vs CLBAX (250). CLBAX annual gain was more profitable for investors over the last year : 17.74 vs. QKBGX (8.75). CLBAX return over 5 years is better than : 37.18 vs. QKBGX (12.24).
CLBAXQKBGXCLBAX / QKBGX
Total Expense Ratio0.581.0555%
Annual Report Gross Expense Ratio0.581.0555%
Fund Existence24 years19 years-
Gain YTD9.6966.391152%
Front Load4%N/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets279B331M84,290%
Annual Yield % from dividends1.781.35132%
Returns for 1 year17.748.75203%
Returns for 3 years45.5232.41140%
Returns for 5 years37.1812.24304%
Returns for 10 years97.8764.34152%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VGZ2.390.02
+0.84%
Vista Gold Corp
SM32.940.27
+0.83%
SM Energy Company
CUBWU10.85N/A
N/A
Lionheart Holdings
PLSE24.26-0.41
-1.66%
Pulse Biosciences
ATOS4.85-0.26
-5.09%
Atossa Therapeutics Inc.